Envoy Medical logo

Envoy Medical(NASDAQ) COCHW

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-92%
5 Year-94%
1 Year-32%
1 Month-15%
$0.04
+0.00%
+0.00Today
Envoy Medical last closing stock price
MetricPriceDate
Last closeUSD 0.042026-10-12
Envoy Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-6.32%USD 0.042026-10-05
1 month-14.89%USD 0.052026-09-11
3 month+33.33%USD 0.032026-07-14
Year to date+2.83%USD 0.042025-12-31
1 year-32.09%USD 0.062025-10-10
3 year-23.08%USD 0.052023-10-12
5 year-93.85%USD 0.652021-10-13
Since inception-92%USD 0.502021-04-23

Envoy Medical Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$207.00K

Net Income (TTM)

-$23.40M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.58 (Low)

Price

$0.04

Volume

1

Open

$0.04

Previous Close

$0.04

Daily Range

$0.03 - $0.04

52-Week Range

$0.02 - $0.10

Estimated Earnings Date

Nov 18, 2026

COCHW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Envoy Medical

Envoy Medical, Inc. specializes in auditory health, developing innovative medical technologies to address hearing impairment. The company offers a comprehensive range of products, including personal sound amplifiers and advanced cochlear implants.

Products and Services
  • Personal sound amplifiers for enhanced hearing experiences
  • Esteem fully implanted active middle ear device for discreet hearing solutions
  • Acclaim cochlear implants designed for severe hearing loss
Growth Outlook
  • Established in 1995, Envoy Medical has a long-standing presence in the auditory health sector
  • Recent rebranding in September 2023 aims to enhance market visibility
  • Continued investment in research and development to drive product innovation
Financial Highlights
  • Q2 2026 revenue of $51,000, showing a slight increase from Q1 2026
  • Net income for Q2 2026 was -$5,982,000, reflecting ongoing operational challenges
  • Cash and cash equivalents stood at $19,679,000 as of June 30, 2026
Envoy Medical, Inc. operates within the medical devices industry, focusing on solutions for hearing impairment. The company has developed a diverse product line that caters to various levels of hearing loss, positioning itself as a key player in the auditory health market. The recent rebranding effort aims to strengthen its market presence and enhance brand recognition. Despite facing operational challenges, the company continues to invest in research and development, which is crucial for driving future growth and innovation. The financial data indicates a commitment to maintaining liquidity, with a significant cash reserve available for ongoing operations and potential expansion. Overall, Envoy Medical presents an intriguing opportunity for investors interested in the healthcare sector, particularly in the growing field of auditory health. The company's established history, innovative product offerings, and strategic focus on research and development may provide a solid foundation for future growth.
AI Generated • Sep 15, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Headquarters

White Bear Lake, MN 55110, US

COCHW Financials

Key Financial Metrics (TTM)

Gross Margin

-385.51%

Operating Margin

-11411.11%

Net Income Margin

-11304.83%

Return on Equity

1719.71%

Return on Capital

N/A

Return on Assets

-97.71%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-5.76%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

1

Avg. Volume

19.33K

Financials (TTM)

Gross Profit

-$798.00K

Operating Income

-$23.62M

EBITDA

-$21.80M

Operating Cash Flow

-$21.53M

Capital Expenditure

-$178.00K

Free Cash Flow

-$21.71M

Cash & ST Invst.

$19.68M

Total Debt

$810.00K

Envoy Medical Performance Analysis

Envoy Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-46.2%
Q42025-12-3178.6%
Q12026-03-31-48.0%
Q22026-06-3030.8%
Envoy Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-9.4%
Q42025-12-3151.4%
Q12026-03-3151.4%
Q22026-06-3015.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$51.00K

-34.6%

Gross Profit

-$227.00K

-45.5%

Gross Margin

-4.45%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

43

N/A

Net Income

-$5.98M

-5.1%

EBITDA

-$5.08M

-2.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$19.68M

+272.2%

Total Debt

$810.00K

-97.2%

Accounts Receivable

$66.00K

+4.8%

Inventory

$1.58M

-0.5%

Long Term Debt

$678.00K

-97.6%

Short Term Debt

$132.00K

-33.3%

Return on Assets

-97.71%

N/A

Return on Invested Capital

-2.09%

N/A

Free Cash Flow

-$5.46M

-22.4%

Operating Cash Flow

-$5.46M

-22.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PETVPetVivo Holdings, Inc.
$0.73+6.10%
CDTCDT Equity Inc.
$0.45-31.82%
WORXSCWorx Corp.
$2.46-22.15%
HEPAHepion Pharmaceuticals, Inc.
$0.06-50.61%

Trending Stocks

Symbol / CompanyPricePrice Chg
CIFRCipher Digital
$11.34-12.77%
BMBLBumble
$5.95+56.58%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$37.42+0.62%
INTCIntel
$102.81+1.44%

Questions About COCHW

What is the current price of Envoy Medical?

Envoy Medical is trading at $0.04 per share.

What is the 52-week range for Envoy Medical?

Over the past 52 weeks, Envoy Medical has traded between $0.02 and $0.10.

How much debt does Envoy Medical have?

Envoy Medical total debt is unavailable.

How much cash does Envoy Medical have on hand?

Envoy Medical does not have cash on hand data available.

What is Envoy Medical’s dividend yield?

Envoy Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services